Annual Moxidectin

2 trials

Sponsors

Medicines Development for Global Health, Higher Institute of Scientific and Medical Research

Conditions

Onchocerciasis

Phase 3

Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis

Active, not recruitingPACTR202004639229710

Medicines Development for Global HealthOnchocerciasis

Start: 2021-02-15Target: 320Updated: 2026-09-14

Eliminating onchocerciasis with Moxidectin in Endemic hotspots of Central Africa (EMINENCE)

Active, not recruitingPACTR202605878416520

Higher Institute of Scientific and Medical ResearchOnchocerciasis

Start: 2025-06-01Target: 285824Updated: 2026-09-14